According to the World Health Organization (WHO), “vaccination against hepatitis A virus be introduced into national immunization schedules for individuals aged ≥12 months, if indicated on the basis of: i) an increasing trend over time of acute hepatitis A disease, including severe disease, among older children, adolescents or adults; ii) changes in the endemicity from high to intermediate; and iii) considerations of cost-effectiveness”[ 6 ].
← all excerpts
Cost-effective analysis of hepatitis A vaccination in Kerala state, India.
1
—
—